Radionuclide imaging in ischemic stroke

Journal of Nuclear Medicine

Volumn 55, Issue 11, 2014, Pages 1831-1841

  Heiss, Wolf Dieter ^a  

^a MAX PLANCK INSTITUTE FOR NEUROLOGICAL RESEARCH   (Germany)

Author keywords

Cerebral ischemia; Diaschisis; Functional activation; Hemodynamic reserve; Infarction; Neuroinflammation; Penumbra; PET; Reperfusion; SPECT; Stroke

Indexed keywords

1 FLUORO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL F 18; ALTEPLASE; CARBON 11; CARBON 14; CYSTEINE ETHYL ESTER TC 99M; FLUMAZENIL C 11; FLUORINE 18; GALACTO RGD F 18; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; IOFETAMINE I 123; IOMAZENIL I 123; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; OXYGEN 15; RADIOISOTOPE; UNCLASSIFIED DRUG; CARBON; FLUMAZENIL;

ARTERIOSCLEROSIS; ARTICLE; BRAIN BLOOD FLOW; BRAIN BLOOD VESSEL; BRAIN DAMAGE; BRAIN DYSFUNCTION; BRAIN FUNCTION; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN METABOLISM; CEREBROVASCULAR DISEASE; CLINICAL DECISION MAKING; DRUG BINDING; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG UPTAKE; HUMAN; INVASIVE PROCEDURE; NERVE CELL LESION; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PREDICTION; REHABILITATION CARE; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYMPTOM; TISSUE INJURY; ANIMAL; ANOXIA; BRAIN; CEREBROVASCULAR ACCIDENT; CHEMISTRY; DIAGNOSTIC USE; INFLAMMATION; MICROGLIA; PATHOLOGY;

ANIMALS; ANOXIA; BRAIN; BRAIN ISCHEMIA; CARBON RADIOISOTOPES; CEREBROVASCULAR DISORDERS; FLUMAZENIL; HUMANS; INFLAMMATION; MICROGLIA; POSITRON-EMISSION TOMOGRAPHY; RADIOISOTOPES; STROKE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84910660896     PISSN: 01615505     EISSN: 2159662X     Source Type: Journal    
DOI: 10.2967/jnumed.114.145003     Document Type: Article

References (100)

1. Kety SS, Schmidt CF. The determination of cerebral blood flow in man by the use of nitrous oxide in low concentrations. Am J Physiol. 1945;143:53-66.
2. Ingvar DH, Lassen NA. Quantitative determination of regional cerebral blood flow in man. Lancet. 1961;278:806-807.
3. Glass HI, Harper AM. Measurement of regional blood flow in cerebral cortex of man through intact skull. Br Med J. 1963;1:593.
4. Ingvar DH, Cronqvist S, Ekberg R, Risberg J, Hoedt-Rasmussen K. Normal values of regional cerebral blood flow in man, including flow and weight estimates of grey and white matter. Acta Neurol Scand. 1965;41(suppl 14):72-78.
5. Heiss WD, Prosenz P, Roszuczky A. Technical considerations in the use of a gamma camera 1,600-channel analyzer system for the measurement of regional cerebral blood flow. J Nucl Med. 1972;13:534-543.
6. Hoedt-Rasmussen K, Skinhoj E, Paulson O, et al. Regional cerebral blood flow in acute apoplexy: the "luxury perfusion syndrome" of brain tissue. Arch Neurol. 1967;271-281.
7. Kuhl DE, Edwards RQ, Ricci AR, Yacob RJ, Mich TJ, Alavi A. The Mark IV system for radionuclide computed tomography of the brain. Radiology. 1976;121:405-413.
8. Ter-Pogossian MM, Phelps ME, Hoffman EJ, Mullani NA. A positron emission transaxial tomograph for nuclear imaging (PETT). Radiology. 1975;114:89-98.
9. Pakkenberg B, Gundersen HJ. Neocortical neuron number in humans: effect of sex and age. J Comp Neurol. 1997;384:312-320.
10. Clarke DD, Sokoloff L. Circulation and energy metabolism of the brain. In: Siegel G, Agranoff B, Albers RW, Fisher S, eds. Basic Neurochemistry: Molecular, Cellular, and Medical Aspects. 6th ed. Philadelphia, PA: Lippincott-Raven; 1999:637-669.
11. Howarth C, Gleeson P, Attwell D. Updated energy budgets for neural computation in the neocortex and cerebellum. J Cereb Blood Flow Metab. 2012;32: 1222-1232.
12. Reivich M, Kuhl D, Wolf A, et al. The [18F]fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man. Circ Res. 1979;44: 127-137.
13. Silverman DHS, Melega WP. Molecular imaging of biologic processes with PET: evaluating biologic bases of cerebral function. In: Phelps ME, ed. PET: Molecular Imaging and Its Biological Application. New York, NY: Springer; 2003:509-583.
14. Holman BL, Devous MD Sr. Functional brain SPECT: the emergence of a powerful clinical method. J Nucl Med. 1992;33:1888-1904.
15. Asenbaum S, Brücke T, Pirker W, Pietrzyk U, Podreka I. Imaging of cerebral blood flow with technetium-99m-HMPAO and technetium-99m-ECD: a comparison. J Nucl Med. 1998;39:613-618.
16. Matsuda H, Yagishita A, Tsuji S, Hisada K. A quantitative approach to technetium-99m ethyl cysteinate dimer: a comparison with technetium-99m hexamethylpropylene amine oxime. Eur J Nucl Med. 1995;22:633-637.
17. Lassen NA, Henriksen L, Paulson OB. Regional cerebral blood flow by radioxenon-113 inhalation and dynamic emission tomography. Prog Nucl Med. 1981;7:110-117.
18. Phelps ME, Huang SC, Hoffman EJ, Kuhl DE. Validation of tomographic measurement of cerebral blood volume with C-11-labeled carboxyhemoglobin. J Nucl Med. 1979;20:328-334.
19. Martin WRW, Powers WJ, Raichle ME. Cerebral blood volume measured with inhaled C15O and positron emission tomography. J Cereb Blood Flow Metab. 1987;7:421-426.
20. Raichle ME, Martin WR, Herscovitch P, Mintun MA, Markham J. Brain blood flow measured with intravenous H2 15O. II. Implementation and validation. J Nucl Med. 1983;24:790-798.
21. Frackowiak RSJ, Lenzi GL, Jones T, Heather JD. Quantitative measurement of regional cerebral blood flow and oxygen metabolism in man using 15O and positron emission tomography: theory, procedure, and normal values. J Comput Assist Tomogr. 1980;4:727-736.
22. Mintun MA, Raichle ME, Martin WRW, Herscovitch P. Brain oxygen utilization measured with O-15 radiotracers and positron emission tomography. J Nucl Med. 1984;25:177-187.
23. Huang SC, Feng DG, Phelps ME. Model dependency and estimation reliability in measurement of cerebral oxygen utilization rate with oxygen-15 and dynamic positron emission tomography. J Cereb Blood Flow Metab. 1986;6:105-119.
24. Sokoloff L, Reivich M, Kennedy C, et al. The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem. 1977;28:897-916.
25. Paulson OB. Cerebral apoplexy (stroke): pathogenesis, pathophysiology and therapy as illustrated by regional blood flow measurements in the brain. Stroke. 1971;2:327-360.
26. Heiss WD. Regional cerebral blood flow measurement using a scintillation camera. Clin Nucl Med. 1979;4:385-396.
27. Kushner M, Reivich M, Fieschi C, et al. Metabolic and clinical correlates of acute ischemic infarction. Neurology. 1987;37:1103-1110.
28. Raynaud C, Rancurel G, Tzourio N, et al. SPECT analysis of recent cerebral infarction. Stroke. 1989;20:192-204.
29. Brass LM, Walovitch RC, Joseph JL, et al. The role of single photon emission computed tomography brain imaging with 99mTc-bicisate in the localization and definition of mechanism of ischemic stroke. J Cereb Blood Flow Metab. 1994; 14(suppl 1):S91-S98.
30. Kuhl DE, Phelps ME, Kowell AP, Metter EJ, Selin C,Winter J. Effects of stroke on local cerebral metabolism and perfusion: mapping by emission computed tomography of 18FDG and 13NH3. Ann Neurol. 1980;8:47-60.
31. Wise RJS, Bernardi S, Frackowiak RSJ, Legg NJ, Jones T. Serial observations on the pathophysiology of acute stroke: the transition from ischaemia to infarction as reflected in regional oxygen extraction. Brain. 1983;106:197-222.
32. Lassen NA. The luxury-perfusion syndrome and its possible relation to acute metabolic acidosis localized within the brain. Lancet. 1966;2:1113-1115.
33. Berrouschot J, Barthel H, Hesse S, Koster J, Knapp WH, Schneider D. Differentiation between transient ischemic attack and ischemic stroke within the first 6 hours after onset of symptoms by using 99mTc-ECD-SPECT. J Cereb Blood Flow Metab. 1998;18:921-929.
34. Powers WJ. Cerebral hemodynamics in ischemic cerebrovascular disease. Ann Neurol. 1991;29:231-240.
35. Ueda T. Can the penumbra be imaged using single-photon emission computed tomography? In: Donnan GA, Baron JC, Davis SM, Sharp FR, eds. The Ischemic Penumbra. Boca Raton, FL: CRC Press; 2007:165-175.
36. Marchal G, Serrati C, Rioux P, et al. PET imaging of cerebral perfusion and oxygen consumption in acute ischaemic stroke: relation to outcome. Lancet. 1993;341:925-927.
37. Hossmann KA. Pathophysiological basis of translational stroke research. Folia Neuropathol. 2009;47:213-227.
38. Astrup J, Siesjö BK, Symon L. Thresholds in cerebral ischemia: the ischemic penumbra. Stroke. 1981;12:723-725.
39. Heiss WD, Rosner G. Functional recovery of cortical neurons as related to degree and duration of ischemia. Ann Neurol. 1983;14:294-301.
40. Ackerman RH, Correia JA, Alpert NM, et al. Positron imaging in ischemic stroke disease using compounds labeled with oxygen 15: initial results of clinicophysiologic correlations. Arch Neurol. 1981;38:537-543.
41. Baron JC, Bousser MG, Comar D, Soussaline F, Castaigne P. Noninvasive tomographic study of cerebral blood flow and oxygen metabolism in vivo: potentials, limitations, and clinical applications in cerebral ischemic disorders. Eur Neurol. 1981;20:273-284.
42. Lenzi GL, Frackowiak RSJ, Jones T. Cerebral oxygen metabolism and blood flow in human cerebral ischemic infarction. J Cereb Blood Flow Metab. 1982;2:321-335.
43. Powers WJ, Grubb RL Jr., Darriet D, Raichle ME. Cerebral blood flow and cerebral metabolic rate of oxygen requirements for cerebral function and viability in humans. J Cereb Blood Flow Metab. 1985;5:600-608.
44. Heiss WD. Ischemic penumbra: evidence from functional imaging in man. J Cereb Blood Flow Metab. 2000;20:1276-1293.
45. Powers WJ, Zazulia AR. PET in cerebrovascular disease. PET Clin. 2010;5: 83106.
46. Baron JC. Mapping the ischaemic penumbra with PET: implications for acute stroke treatment. Cerebrovasc Dis. 1999;9:193-201.
47. Heiss WD, Huber M, Fink GR, et al. Progressive derangement of periinfarct viable tissue in ischemic stroke. J Cereb Blood Flow Metab. 1992;12:193-203.
48. Sasaki O, Takeuchi S, Koizumi T, Koike T, Tanaka R. Complete recanalization via fibrinolytic therapy can reduce the number of ischemic territories that progress to infarction. Am J Neuroradiol. 1996;17:1661-1668.
49. Iseda T, Nakano S, Yano T, Suzuki Y, Wakisaka S. Time-threshold curve determined by single photon emission CT in patients with acute middle cerebral artery occlusion. AJNR. 2002;23:572-576.
50. Watanabe Y, Takagi H, Aoki S, Sassa H. Prediction of cerebral infarct sizes by cerebral blood flow SPECT performed in the early acute stage. Ann Nucl Med. 1999;13:205-210.
51. Umemura A, Suzuka T, Yamada K. Quantitative measurement of cerebral blood flow by 99mTc-HMPAO SPECT in acute ischaemic stroke: usefulness in determining therapeutic options. J Neurol Neurosurg Psychiatry. 2000;69:472-478.
52. Guadagno JV, Jones PS, Aigbirhio FI, et al. Selective neuronal loss in rescued penumbra relates to initial hypoperfusion. Brain. 2008;131:2666-2678.
53. Nakagawara J, Sperling B, Lassen NA. Incomplete brain infarction of reperfused cortex may be quantitated with iomazenil. Stroke. 1997;28:124-132.
54. Chida K, Ogasawara K, Kuroda H, et al. Central benzodiazepine receptor binding potential and CBF images on SPECT correlate with oxygen extraction fraction images on PET in the cerebral cortex with unilateral major cerebral artery occlusive disease. J Nucl Med. 2011;52:511-518.
55. Saur D, Buchert R, Knab R, Weiller C, Rother J. Iomazenil-single-photon emission computed tomography reveals selective neuronal loss in magnetic resonance-defined mismatch areas. Stroke. 2006;37:2713-2719.
56. Kidwell CS, Alger JR, Saver JL. Beyond mismatch: evolving paradigms in imaging the ischemic penumbra with multimodal magnetic resonance imaging. Stroke. 2003;34:2729-2735.
57. Sobesky J, Weber OZ, Lehnhardt FG, et al. Does the mismatch match the penumbra? Magnetic resonance imaging and positron emission tomography in early ischemic stroke. Stroke. 2005;36:980-985.
58. Zaro-Weber O, Moeller-Hartmann W, Heiss W-D, Sobesky J. The performance of MRI-based cerebral blood flow measurements in acute and subacute stroke compared with 15O-water positron emission tomography: identification of penumbral flow. Stroke. 2009;40:2413-2421.
59. Yeh SH, Liu RS, Hu HH, et al. Ischemic penumbra in acute stroke: demonstration by PET with fluorine-18 fluoromisonidazole [abstract]. J Nucl Med. 1994; 35(suppl):205P.
60. Read SJ, Hirano T, Abbott DF, et al. Identifying hypoxic tissue after acute ischemic stroke using PET and 18F-fluoromisonidazole. Neurology. 1998;51:1617-1621.
61. Markus R, Donnan G, Kazui S, Read S, Reutens D. Penumbral topography in human stroke: methodology and validation of the 'Penumbragram.' Neuroimage. 2004;21:1252-1259.
62. Alawneh JA, Moustafa RR, Marrapu ST, et al. Diffusion and perfusion correlates of the 18F-MISO PET lesion in acute stroke: pilot study. Eur J Nucl Med Mol Imaging. 2014;41:736-744.
63. Lees KR, Bluhmki E, von Kummer R, et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet. 2010;375:1695-1703.
64. Grotta JC, Alexandrov AV. tPA-Associated reperfusion after acute stroke demonstrated by SPECT. Stroke. 1998;29:429-432.
65. Heiss WD, Grond M, Thiel A, et al. Tissue at risk of infarction rescued by early reperfusion: a positron emission tomography study in systemic recombinant tissue plasminogen activator thrombolysis of acute stroke. J Cereb Blood Flow Metab. 1998;18:1298-1307.
66. Heiss WD, Kracht L, Grond M, et al. Early [11C]flumazenil/H2O positron emission tomography predicts irreversible ischemic cortical damage in stroke patients receiving acute thrombolytic therapy. Stroke. 2000;31:366-369.
67. Ueda T, Sakaki S, Yuh WTC, Nochide I, Ohta S. Outcome in acute stroke with successful intra-Arterial thrombolysis and predictive value of initial single-photon emission-computed tomography. J Cereb Blood Flow Metab. 1999;19:99-108.
68. Nakano S, Iseda T, Ikeda T, Yoneyama T, Wakisaka S. Thresholds of ischemia salvageable with intravenous tissue plasminogen activator therapy: evaluation with cerebral blood flow single-photon emission computed tomographic measurements. Neurosurgery. 2000;47:68-71.
69. Abumiya T, Katoh M, Moriwaki T, et al. Utility of early post-treatment singlephoton emission computed tomography imaging to predict outcome in stroke patients treated with intravenous tissue plasminogen activator. J Stroke Cerebrovasc Dis. 2014;23:896-901.
70. Jüttler E, Bosel J, Amiri H, et al. DESTINY II: DEcompressive Surgery for the Treatment of malignant INfarction of the middle cerebral arterY II. Int J Stroke. 2011;6:79-86.
71. Dohmen C, Bosche B, Graf R, et al. Prediction of malignant course in middle cerebral artery infarction by PET and microdialysis. Stroke. 2003;34:2152-2158.
72. Thiel A, Heiss WD. Imaging of microglia activation in stroke. Stroke. 2011;42: 507-512.
73. Schroeter M, Dennin MA, Walberer M, et al. Neuroinflammation extends brain tissue at risk to vital peri-infarct tissue: a double tracer [11C]PK11195-And [18F]FDG-PET study. J Cereb Blood Flow Metab. 2009;29:1216-1225.
74. Weinstein JR, Koerner IP, Moller T. Microglia in ischemic brain injury. Future Neurol. 2010;5:227-246.
75. Gerhard A, Schwarz J, Myers R, Wise R, Banati RB. Evolution of microglial activation in patients after ischemic stroke: a [11C](R)-PK11195 PET study. Neuroimage. 2005;24:591-595.
76. Radlinska BA, Ghinani SA, Lyon P, et al. Multimodal microglia imaging of fiber tracts in acute subcortical stroke. Ann Neurol. 2009;66:825-832.
77. Gibbs JM, Wise RJ, Leenders KL, Jones T. Evaluation of cerebral perfusion reserve in patients with carotid-Artery occlusion. Lancet. 1984;1:310-314.
78. Gupta A, Baradaran H, Schweitzer AD, et al. Oxygen extraction fraction and stroke risk in patients with carotid stenosis or occlusion: a systematic review and meta-Analysis. AJNR. 2014;35:250-255.
79. Matsubara S, Moroi J, Suzuki A, et al. Analysis of cerebral perfusion and metabolism assessed with positron emission tomography before and after carotid artery stenting: clinical article. J Neurosurg. 2009;111:28-36.
80. Oka F, Ishihara H, Kato S, Higashi M, Suzuki M. Cerebral hemodynamic benefits after contralateral carotid artery stenting in patients with internal carotid artery occlusion. AJNR. 2013;34:616-621.
81. Abe A, Ueda T, Ueda M, Nogoshi S, Nishiyama Y, Katayama Y. Recovery of cerebrovascular reserves after stenting for symptomatic carotid artery stenosis. Interv Neuroradiol. 2010;16:420-428.
82. Baron JC, Yamauchi H, Fujioka M, Endres M. Selective neuronal loss in ischemic stroke and cerebrovascular disease. J Cereb Blood Flow Metab. 2014;34:2-18.
83. Powers WJ, Clarke WR, Grubb RL Jr., et al. Extracranial-intracranial bypass surgery for stroke prevention in hemodynamic cerebral ischemia: the Carotid Occlusion Surgery Study randomized trial. JAMA. 2011;306:1983-1992.
84. Feeney DM, Baron JC. Diaschisis. Stroke. 1986;17:817-830.
85. Sobesky J, Thiel A, Ghaemi M, et al. Crossed cerebellar diaschisis in acute human stroke: a PET study of serial changes and response to supratentorial reperfusion. J Cereb Blood Flow Metab. 2005;25:1685-1691.
86. Liu Y, Karonen JO, Nuutinen J, Vanninen E, Kuikka JT, Vanninen RL. Crossed cerebellar diaschisis in acute ischemic stroke: a study with serial SPECT and MRI. J Cereb Blood Flow Metab. 2007;27:1724-1732.
87. Szelies B, Herholz K, Pawlik G, Karbe H, Hebold I, Heiss WD. Widespread functional effects of discrete thalamic infarction. Arch Neurol. 1991;48: 178-182.
88. Szilágyi G, Vas A, Kerenyi L, Nagy Z, Csiba L, Gulyas B. Correlation between crossed cerebellar diaschisis and clinical neurological scales. Acta Neurol Scand. 2012;125:373-381.
89. Ingvar DH. Functional landscapes of the dominant hemisphere. Brain Res. 1976;107:181-197.
90. Phelps ME, Mazziotta JC. Positron emission tomography: human brain function and biochemistry. Science. 1985;228:799-809.
91. Rijntjes M, Weiller C. Recovery of motor and language abilities after stroke: the contribution of functional imaging. Prog Neurobiol. 2002;66:109-122.
92. Nelles G, Jentzen W, Jueptner M. Müller S, Diener HC. Arm training induced brain plasticity in stroke studied with serial positron emission tomography. Neuroimage. 2001;13:1146-1154.
93. Murase N, Duque J, Mazzocchio R, Cohen LG. Influence of interhemispheric interactions on motor function in chronic stroke. Ann Neurol. 2004;55: 400-409.
94. Hsu WY, Cheng CH, Liao KK, Lee IH, Lin YY. Effects of repetitive transcranial magnetic stimulation on motor functions in patients with stroke: a metaanalysis. Stroke. 2012;43:1849-1857.
95. Heiss WD, Thiel A, Winhuisen L, Mühlberger B, Kessler J, Herholz K. Functional imaging in the assessment of capability for recovery after stroke. J Rehabil Med. 2003;41:27-33.
96. Saur D, Lange R, Baumgaertner A, et al. Dynamics of language reorganization after stroke. Brain. 2006;129:1371-1384.
97. Thiel A, Hartmann A, Rubi-Fessen I, et al. Effects of noninvasive brain stimulation on language networks and recovery in early poststroke aphasia. Stroke. 2013;44:2240-2246.
98. Catana C, Drzezga A, Heiss WD, Rosen BR. PET/MRI for neurologic applications. J Nucl Med. 2012;53:1916-1925.
99. Hsu AR, Chen X. Advances in anatomic, functional, and molecular imaging of angiogenesis. J Nucl Med. 2008;49:511-514.
100. Hoehn M, Himmelreich U, Kruttwig K, Wiedermann D. Molecular and cellular MR imaging: potentials and challenges for neurological applications. J Magn Reson Imaging. 2008;27:941-954.